Immix Biopharma, Inc. IMMX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s common stock?
- Immix Biopharma, Inc. (IMMX) reported common stock of 200M in Q1 2026.
- How has Immix Biopharma, Inc.'s common stock changed year-over-year?
- Immix Biopharma, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Immix Biopharma, Inc.'s common stock?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s common stock has grown at a 58.5% compound annual growth rate (CAGR), from 20M to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).